Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0118
BRL/USD 0,1941
0,0001
INR/USD 0,0104
CNY/USD 0,1488
0,0002
ZAR/USD 0,0613
0,0002
IDR/USD 0,0001
SPACE FOR MEDIA DIPLOMACY
13:30 «BRICSdialogue»
13:30 «BRICSdialogue»
Now 16+
13:30

«BRICSdialogue»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
14:00 «Russian Lessons with Tanya Semke»
Next
14:00

«Russian Lessons with Tanya Semke»

16+
14:15

«Laboratorium»

16+
14:30

«Lеt's be clear»

16+
Menu

Indian scientists identify common biomarkers for early detection of pancreatic and glioma cancers

The findings contribute to advancements in personalised medicine

Indian researchers have identified common metabolites associated with pancreatic and glioma cancers, paving the way for improved early diagnosis and more effective treatments. This is reported by IANS, a partner of TV BRICS.

The study focused on metabolites found in exosomes – nano-sized vesicles that carry tumour-derived compounds – originating from pancreatic, lung, and glioma cancer cell lines. These biomarkers offer a promising non-invasive method for early detection, addressing a critical gap in diagnosing aggressive cancers that are often identified in advanced stages.

The research team employed a multi-technique approach that integrated Nanoparticle Tracking Analysis (NTA), Electron Microscopy (EM), Western Blot (WB), Fourier Transformed Infrared Spectroscopy (FTIR), untargeted Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), and Nuclear Magnetic Resonance (NMR). This comprehensive methodology provides a more precise characterisation of exosomes compared to conventional single-method studies, as reported by the source.

Experts believe this breakthrough could significantly improve treatment efficacy, particularly through personalised therapies designed to interfere with dysregulated metabolic pathways in cancer cells. Such targeted interventions hold the potential to reduce side effects and enhance patient outcomes, marking a significant step forward in cancer diagnostics and therapeutics, the source claims.

Photo: iStock